Dr. Sara M. Tolaney, MD MPH
Claim this profileDana Farber Cancer Institute
Expert in Breast Cancer
Studies Breast cancer
14 reported clinical trials
28 drugs studied
Area of expertise
1Breast Cancer
Global LeaderStage IV
HER2 negative
Stage III
2Breast Cancer
HER2 negative
ER negative
PR negative
Affiliated Hospitals
Clinical Trials Sara M. Tolaney, MD MPH is currently running
Elacestrant Combinations
for Breast Cancer
This is a multicenter, Phase 1b/2 trial. The phase 1b part of the trial aims to determine the RP2D of elacestrant when administered in combination with alpelisib, everolimus, palbociclib, abemaciclib, and ribociclib. The Phase 2 part of the trial will evaluate the efficacy and safety of the various combinations in patients with ER+/HER2- advanced/metastatic breast cancer.
Recruiting1 award Phase 1 & 2
Sacituzumab Govitecan + Pembrolizumab
for Triple Negative Breast Cancer
This research study involves testing the safety and efficacy of an investigational intervention for patients with triple-negative breast cancer (TNBC) that has spread, or metastasized, to other parts the body and is PD-L1-negative. The names of the study interventions involved in this study are: * Sacituzumab govitecan (Trodelvy™;IMMU-132) * Pembrolizumab (Keytruda®; MK-3475)
Recruiting1 award Phase 215 criteria
More about Sara M. Tolaney, MD MPH
Clinical Trial Related7 years of experience running clinical trials · Led 14 trials as a Principal Investigator · 5 Active Clinical TrialsTreatments Sara M. Tolaney, MD MPH has experience with
- Pembrolizumab
- Sacituzumab Govitecan
- Biopsy
- Abemaciclib
- Olaparib
- Sapacitabine
Breakdown of trials Sara M. Tolaney, MD MPH has run
Breast Cancer
Breast cancer
Retinoblastoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Sara M. Tolaney, MD MPH specialize in?
Sara M. Tolaney, MD MPH focuses on Breast Cancer and Breast cancer. In particular, much of their work with Breast Cancer has involved Stage IV patients, or patients who are HER2 negative.
Is Sara M. Tolaney, MD MPH currently recruiting for clinical trials?
Yes, Sara M. Tolaney, MD MPH is currently recruiting for 5 clinical trials in Boston Massachusetts. If you're interested in participating, you should apply.
Are there any treatments that Sara M. Tolaney, MD MPH has studied deeply?
Yes, Sara M. Tolaney, MD MPH has studied treatments such as Pembrolizumab, Sacituzumab Govitecan, Biopsy.
What is the best way to schedule an appointment with Sara M. Tolaney, MD MPH?
Apply for one of the trials that Sara M. Tolaney, MD MPH is conducting.
What is the office address of Sara M. Tolaney, MD MPH?
The office of Sara M. Tolaney, MD MPH is located at: Dana Farber Cancer Institute, Boston, Massachusetts 02215 United States. This is the address for their practice at the Dana Farber Cancer Institute.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.